Sort   by:  
 Page size 
ProteomicsLarge-scale discovery proteomics - Nitrospira moscoviensis
A large-scale discovery proteomics experiment was performed on biomass of Nitrospira moscoviensis (Lab head, Dr. Sebastian Lücker, RU, NL). The soluble protein fraction was analysed following high pH reverse-phase peptide fractionation. The insoluble membrane fraction was solubilised by an optimised...
ORGANISM(S): Nitrospira moscoviensis 
2021-07-22 | PXD019583 | Pride
Qe plus Nitrospira moscoviensis Shot-gun proteomics 
UnknownMutations in multiple components of the nuclear pore complex cause nephrotic syndrome.
Not available
S-EPMC6159964 | biostudies-literature
UnknownAntibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab.
Not available
S-EPMC8927425 | biostudies-literature
UnknownElectrodiagnostic subtyping in Guillain-Barre syndrome patients in the International Guillain-Barre Outcome Study.
Not available
S-EPMC11295174 | biostudies-literature
UnknownUpdate on the third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruited.
Not available
S-EPMC3286387 | biostudies-literature
UnknownPatient care and clinical outcomes for patients with COVID-19 infection admitted to African high-care or intensive care units (ACCCOS): a multicentre, prospective, observational cohort study.
Not available
S-EPMC8137309 | biostudies-literature
UnknownNeutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study.
Not available
S-EPMC9757903 | biostudies-literature
UnknownLong-term Outcomes with Spinal versus General Anesthesia for Hip Fracture Surgery: A Randomized Trial.
Not available
S-EPMC11186520 | biostudies-literature
UnknownPrehospital use of magnesium sulfate as neuroprotection in acute stroke.
Not available
S-EPMC4920545 | biostudies-literature
UnknownThe benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial.
Not available
S-EPMC3386495 | biostudies-literature
Sort   by:  
 Page size